Zymeworks Inc (ZYME)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Zymeworks Advances Cutting-Edge Therapies at AACR Annual Meeting
Zymeworks Inc. Spearheads Transformation in Biotechnology Landscape with Ambitious Strategic Vision
Zymeworks* Promising Future: Inclusion in Nasdaq Biotechnology Index Amplifies Growth Prospects
Zymeworks Inc. Faces Financial Setback in Fourth Quarter of 2023
Zymeworks Inc Demonstrates Remarkable Performance Surge in the Third Quarter of 2023
Zymeworks Inc Achieves Impressive 28.666% Revenue Surge, Outperforming Industry Averages
Robust 48.56% Top-line rise at ZYME in the most recent fiscal period
A Blowout results, by ZYME over the second quarter of 2022